ACUTE KIDNEY INJURY TREATMENT MARKET ANALYSIS

Acute Kidney Injury Treatment Market Size and Trends

Global acute kidney injury treatment market is estimated to be valued at USD 1.81 Bn in 2024 and is expected to reach USD 3.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

To learn more about this report, Request sample copy

Increasing risk factors associated with acute kidney injury such as increasing aging population, growing incidence of diabetes and hypertension, and rising number of surgeries can drive the market growth. Moreover, development and approval of newer drugs for acute kidney injury treatment along with availability of advanced dialysis technologies can also drive the market growth. However, lack of awareness about acute kidney diseases especially in developing nations and high cost of treatment procedures can hamper the market growth. Increasing research activities and stringent regulatory guidelines to minimize drug-induced kidney injuries can offer lucrative opportunities for the acute kidney injury treatment market players over the forecast period.

Increasing number of hospitalization cases

With growing prevalence of various chronic conditions and lifestyle diseases across the world, there has been increase in number of hospital admissions over the past few decades.

Prolonged hospital stays often necessitate the use of potent medications, intravenous contrast agents, and other invasive procedures, which can overburden the kidneys and impair their normal functioning. The hospital environment also increases the risk of acquiring infections like sepsis, which is one of the leading causes of acute kidney injuries. Moreover, major surgeries, especially those involving the cardiovascular or gastrointestinal systems, place heavy stress on the kidneys. As global disease burden increases, more complex procedures are being performed to manage advanced cases that  further elevates the risk. Therefore, with continually swelling patient volumes inside hospitals and longer average hospitalization times, patients are more susceptible to acute renal complications.

To learn more about this report, Request sample copy

Rising burden of chronic diseases like diabetes

Chronic medical conditions have emerged as the foremost challenge for healthcare systems worldwide. Rising prevalence of lifestyle-related long-term disorders especially diabetes and hypertension is the major trend in the market. These non-communicable diseases have turned into silent epidemics engulfing both developed and developing populations alike. Both diabetes and high blood pressure are significant risk factors for kidney diseases as these can cause steady damage to the renal structures over extended periods of time, if not properly managed.

As more people live with diabetes and hypertension for many years without control, the risk of eventually developing chronic kidney disease and end-stage renal failure has multiplied substantially. Other chronic conditions like autoimmune diseases and glomerulonephritis are also linked to long-term renal impairment. Ageing global demographics with more elderly susceptible to co-morbidities further exacerbates the chronic disease dynamics. As populations suffer from metabolic, cardiovascular and other long-standing illnesses, their odds of acquiring acute renal problems superimposed upon crumbled kidney functions climbs up considerably.